World Health Organization Sounds Warning Over Acute Shortage of Weight-Loss Injections
Fewer than 10% of individuals eligible to benefit from GLP-1 drugs such as Wegovy have access to them, caution the World Health Organization as it releases its first advice on the medications.
Given in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is urging broader and more equitable access to these injectable treatments.
According to forecasts, in excess of 2,000,000,000 could be obese by 2030 unless action is taken.
"Our new guidelines affirms that obesity is a long-term condition that can be managed with comprehensive and continuous care," remarked its chief Tedros Adhanom Ghebreyesus.
Significant expense, constrained manufacturing, and supply-chain constraints are key barriers to universal availability to the jabs that can assist patients in reducing significant body mass, explains the agency.
Weight-Loss Drug Scarcity
Even under the current most favorable outlook, the manufacturing of such drugs could only cover approximately 100 million people – fewer than 10% of eligible patients, according to the WHO.
The guideline encourages nations and manufacturers to increase access, through measures like licensing agreements.
The intellectual property rights on the active ingredient – the core component of the drug Wegovy – is due to expire in several nations in 2026.
The Way Obesity Jabs Operate
GLP-1 drugs imitate a natural hormone to delay gastric emptying, curb appetite and increase the sense of being full so people consume fewer calories.
Patients commonly start to lose weight within a few weeks of starting on the regular doses.
Studies indicates users may regain a significant portion after a year of stopping the drug, when their normal food cravings come back.
To be above a healthy weight elevates your chance for developing health problems, like type 2 diabetes, cardiovascular issues, stroke, and certain malignancies.
Obesity concerns individuals in all nations and was responsible for millions of fatalities worldwide in 2024, as per the WHO.
